KIORA PHARMACEUTICALS, INC. Increase (Decrease) in Contract with Customer, Asset
KIORA PHARMACEUTICALS, INC. (KPRX) reported Increase (Decrease) in Contract with Customer, Asset of $0 for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerAsset · last filed 2020-03-04
- KIORA PHARMACEUTICALS, INC. increase (decrease) in contract with customer, asset for the quarter ending 2019-09-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in contract with customer, asset for the quarter ending 2019-06-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in contract with customer, asset for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in contract with customer, asset for the quarter ending 2018-12-31 was $0.00.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in contract with customer, asset for fiscal 2018 was $689.93K.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in contract with customer, asset for fiscal 2017 was $0.00.
| Period end | Increase (Decrease) in Contract with Customer, Asset 3 month | Increase (Decrease) in Contract with Customer, Asset 6 month | Increase (Decrease) in Contract with Customer, Asset 9 month | Increase (Decrease) in Contract with Customer, Asset 12 month |
|---|---|---|---|---|
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | $0.00 derived: sum of 4 quarters · filed 2020-03-04 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | $0.00 derived: sum of 3 quarters · filed 2020-03-04 | $0.00 derived: sum of 4 quarters · filed 2020-03-04 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-08 | $0.00 derived: sum of 2 quarters · filed 2020-03-04 | $0.00 derived: sum of 3 quarters · filed 2020-03-04 | -$116.28K derived: sum of 4 quarters · filed 2020-03-04 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | $0.00 derived: sum of 2 quarters · filed 2020-03-04 | -$116.28K derived: sum of 3 quarters · filed 2020-03-04 | $689.93K 10-K · filed 2020-03-04 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$116.28K derived: sum of 2 quarters · filed 2019-11-07 | $689.93K 10-Q · filed 2019-11-07 | $689.93K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | -$116.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $689.93K 10-Q · filed 2019-08-08 | $689.93K derived: sum of 3 quarters · filed 2019-08-08 | |
| 2018-03-31 | $806.21K 10-Q · filed 2019-05-08 | $806.21K derived: sum of 2 quarters · filed 2019-05-08 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $0.00 10-K · filed 2019-03-01 | ||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |